VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
Frequently asked questions
What sector does Volitionrx Ltd (VNRX) operate in?
Volitionrx Ltd belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Volitionrx Ltd (VNRX) current stock price?
As of the latest data, Volitionrx Ltd stock price is $0.18, with a previous close of $0.17. Volitionrx Ltd gained $0.00 in the last trading session, representing a 2.58% increase.
What is Volitionrx Ltd (VNRX) current market capitalization?
Volitionrx Ltd market cap is approximately 4.98 million.
What is Volitionrx Ltd (VNRX) Earnings Per Share (EPS)?
The trailing EPS is -$3.85, and the forward EPS is -$0.85.
What is Volitionrx Ltd (VNRX) EBITDA?
Volitionrx Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -1.74 million.
Does Volitionrx Ltd (VNRX) pay dividends?
No. Volitionrx Ltd does not pay a dividend.
How did Volitionrx Ltd (VNRX) perform in its most recent earnings report?
In the last report (June 30, 2026), Volitionrx Ltd posted an EPS surprise of -14.71% and a revenue surprise of -15.96%.
What is Volitionrx Ltd (VNRX) beta (volatility) score?
Volitionrx Ltd has a beta of 1.095, meaning its volatility is roughly in line with the market.
